Clinical Trials Logo
  1. Home
  2. Arteriovenous Malformations
  3. NCT03656211

Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation — MAVUFERT  

Arteriovenous Malformations Clinical Trial

Official title:
Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation

Clinical Trial Summary

Uterine arteriovenous malformations (UAVM) are short circuits between systemic arterial and venous networks within the uterus. They are congenital or acquired (in the course of an endo-uterine gesture such as curettage or interventions such as caesareans or myomectomies).

They can be manifested by severe metrorrhagia that can go as far as to put the patient's vital prognosis at risk.

There are no recommendations for the management of UAVM since this pathology is rare and therefore series are performed with few cases. If some of these UAVM disappear spontaneously after a therapeutic abstention, when the clinical context allows it, in case of symptomatic UAVM, a selective embolization with arteriography is often carried out to postpone the hysterectomy of hemostasis.

There are also more marginal management options such as Gonadotropin-Releasing Hormone agonists, methotrexate or curettage that are decided on a case by case basis depending on the symptoms and protocols of each medical team.

Regarding subsequent fertility and pregnancy outcomes after conservative treatment, the number of studies is even lower.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03656211
Study type Observational
Source Rennes University Hospital
Contact
Status Completed
Phase
Start date October 2, 2017
Completion date October 10, 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03306823 - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1 N/A
Recruiting NCT03306836 - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2 N/A
Completed NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors N/A
Recruiting NCT02042326 - Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations Phase 2
Recruiting NCT05484245 - Sonography-guided Resection of Brain Mass Lesions N/A
Recruiting NCT05477680 - Intraoperative Brain Shift Calculation Study N/A
Recruiting NCT05484219 - Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations N/A
Completed NCT04246125 - Patient Skin Dose in Interventional Radiology
Recruiting NCT02879071 - Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
Terminated NCT01801488 - Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm N/A
Recruiting NCT06259292 - Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Recruiting NCT02098252 - Treatment of Brain AVMs (TOBAS) Study N/A
Completed NCT02378883 - Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study N/A
Completed NCT00783523 - Influence of MMP on Brain AVM Hemorrhage Phase 1
Recruiting NCT05276934 - Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)
Recruiting NCT03031873 - Evaluation of Susceptibility-weighted Magnetic Resonance Imaging and 4d-time-resolved Magnetic Resonance Angiography in Brain Arteriovenous Malformations N/A
Withdrawn NCT02079818 - Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System Phase 4
Completed NCT01381952 - Image Quality and Radiation Dose in Angiography N/A
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Active, not recruiting NCT03559556 - Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning Early Phase 1